Down-regulation of substance P receptors during colitis induced by trinitrobenzene sulfonic acid in rats

Neuropeptides

Volumn 30, Issue 5, 1996, Pages 425-428

  Evangelista, S ^a,d   Maggi, M ^b   Renzetti, A R ^c  

^a Ist Farmacobiologico Malesci SpA   (Italy)

^b Laboratori Guidotti SpA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Dept of Pharmacology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; SUBSTANCE P; SUBSTANCE P RECEPTOR; TACHYKININ RECEPTOR ANTAGONIST; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0029970867     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(96)90004-9     Document Type: Article

References (23)

1. Yokota Y, Sasai Y, Tanaka K et al. Molecular characterization of a functional cDNA for rat substance P receptor. J Biol Chem 1989; 264: 17649-17652.
2. Lembeck F. Substance P: from extract to excitement. Acta Physiol Scand 1988; 133: 435-454.
3. Holzer P, Gamse R, Lembeck F. Distribution of substance P in the rat gastrointestinal tract - lack of effect of capsaicin pretreatment. Eur J Pharmacol 1980; 61: 303-307
4. Payan D G. Neuropeptides and inflammation: The role of Substance P. Ann Rev Med 1989; 40: 341-352.
5. Sjolund K, Schaffalitzy de Muckadell O B, Fahrenkrug R, Hakanson R, Peterson B G, Sundler F. Peptide containing nerve fibres in the gut wall in Crohn's disease. Gut 1983; 24: 724-733.
6. Koch T R, Carney J A, Go V L W. Distribution and quantification of gut neuropeptides in normal intestine and inflammatory bowel disease. Dig Dis Sci 1987; 32: 369-376.
7. Goldin E, Karmeli F, Selinger Z, Rachmilewitz D. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig Dis Sci 1989; 34: 754-757.
8. Mantyh C R, Gates T S, Zimmerman R P et al. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by aerterioles, venules and limphonodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci USA 1988; 85: 3235-3239.
9. Mantyh C R, Vigna S R, Maggio J E, Mantyh P W, Bollinger R R, Pappas T N. Substance P binding sites on intestinal lymphoid aggregates and blood vessels in inflammatory bowel disease correspond to authentic NK-1 receptors. Neurosci Lett 1994; 178: 255-259.
10. 1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically. Br J Pharmacol 1993; 109: 259-264.
11. Burcher E, Buck S H, Lovenberg W, Donohue T L O. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder. J Pharmacol Exp Ther 1986; 236: 819-831.
12. Munson P J, Rodbard D. A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107: 220-239.
13. Morris G P, Beck P L, Herridge M S, Depew W T, Szewczuk M R, Wallace J L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
14. Eysselein V E, Reinshagen M, Cominelli F et al. Calcitonin gene-related peptide and substance P decrease in the rabbit colon during colitis. Gastroenterology 1991; 101: 1211-1219.
15. Miampamba M, Chéry-Croze S, Chayvialle J A. Spinal and intestinal levels of substance P, calcitonin gene-related peptide and vasoactive intestinal peptide following perendoscopic injection of formalin in rat colonic wall. Neuropeptides 1992; 22: 73-80.
16. Palmer J M, Greenwood B. Regional content of enteric substance P and vasoactive intestinal peptide during intestinal inflammation in the parasitized ferret. Neuropeptides 1993; 25: 95-103.
17. Reinshagen M, Adler G, Eysselein V E. Substance P gene expression in acute experimental colitis. Regul Pept 1995; 59: 53-58.
18. Ju G, Hokfelt T, Brodin E et al. Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells. Cell Tissue Res 1987; 247: 417-431.
19. Evangelista S, Meli A. Influence of capsaicin-sensitive fibers on experimentally-induced colitis in rats. J Pharm Pharmacol 1989; 41: 574-575.
20. Reinshagen M, Patel A, Sottili M et al. Protective function of extrinsic sensory neurons in acute rabbit experimental colitis. Gastroenterology 1994; 106: 1208-1214.
21. Reinshagen M, Flamig G, Ernst S et al. Protective effect of calcitonin gene-related peptide (CGRP) in chronic experimental colitis in the rat. Gastroenterology 1995; 108: A676.
22. Evangelista S, Tramontana M. Involvement of calcitonin gene-related peptide in rat experimental colitis. J Physiol (Paris) 1993; 87: 277-280.
23. Goso C, Evangelista S, Tramontana M, Manzini S, Blumberg P M, Szallasi A. Topical capsaicin administration protects against trinitrobenzene sulfonic acid-induced colitis in rat. Eur J Pharmacol 1993; 249: 185-190.